Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
Braz. j. med. biol. res ; 49(8): e5409, 2016. graf
Article Dans Anglais | LILACS | ID: lil-787387

Résumé

Due to the presence of the renin-angiotensin system (RAS) in tissues and its specific influence on white adipose tissue, fat cells are possible targets of pharmacological RAS blockers commonly used as anti-hypertensive drugs. In the present study, we investigated the effects of different RAS blockers on fat cell metabolism, more specifically on lipolysis, lipogenesis and oxidation of energy substrates. Isolated primary adipocytes were incubated with different RAS blockers (aliskiren, captopril and losartan) in vitro for 24 h and lipolysis, lipogenesis and glucose oxidation capacities were determined in dose-response assays to a β-adrenergic agonist and to insulin. Although no change was found in lipolytic capacity, the RAS blockers modulated lipogenesis and glucose oxidation in a different way. While captopril decreased insulin-stimulated lipogenesis (−19% of maximal response and −60% of insulin responsiveness) due to reduced glucose derived glycerol synthesis (−19% of maximal response and 64% of insulin responsiveness), aliskiren increased insulin-stimulated glucose oxidation (+49% of maximal response and +292% of insulin responsiveness) in fat cells. Our experiments demonstrate that RAS blockers can differentially induce metabolic alterations in adipocyte metabolism, characterized by a reduction in lipogenic responsiveness or an increase in glucose oxidation. The impact of RAS blockers on adipocyte metabolism may have beneficial implications on metabolic disorders during their therapeutic use in hypertensive patients.


Sujets)
Animaux , Mâle , Système rénine-angiotensine/effets des médicaments et des substances chimiques , Adipocytes/effets des médicaments et des substances chimiques , Antihypertenseurs/pharmacologie , Captopril/pharmacologie , Rat Wistar , Adipocytes/métabolisme , Losartan/pharmacologie , Lipogenèse/effets des médicaments et des substances chimiques , Fumarates/pharmacologie , Amides/pharmacologie , Glucose/métabolisme , Glycérol/métabolisme , Lipolyse/effets des médicaments et des substances chimiques
2.
Braz. j. med. biol. res ; 48(7): 650-653, 07/2015. graf
Article Dans Anglais | LILACS | ID: lil-751343

Résumé

As it is a common observation that obesity tends to occur after discontinuation of exercise, we investigated how white adipocytes isolated from the periepididymal fat of animals with interrupted physical training transport and oxidize glucose, and whether these adaptations support the weight regain seen after 4 weeks of physical detraining. Male Wistar rats (45 days old, weighing 200 g) were divided into two groups (n=10): group D (detrained), trained for 8 weeks and detrained for 4 weeks; and group S (sedentary). The physical exercise was carried out on a treadmill for 60 min/day, 5 days/week for 8 weeks, at 50-60% of the maximum running capacity. After the training protocol, adipocytes isolated from the periepididymal adipose tissue were submitted to glucose uptake and oxidation tests. Adipocytes from detrained animals increased their glucose uptake capacity by 18.5% compared with those from sedentary animals (P<0.05). The same cells also showed a greater glucose oxidation capacity in response to insulin stimulation (34.55%) compared with those from the S group (P<0.05). We hypothesize that, owing to the more intense glucose entrance into adipose cells from detrained rats, more substrate became available for triacylglycerol synthesis. Furthermore, this increased glucose oxidation rate allowed an increase in energy supply for triacylglycerol synthesis. Thus, physical detraining might play a role as a possible obesogenic factor for increasing glucose uptake and oxidation by adipocytes.


Sujets)
Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Maladies des agriculteurs/induit chimiquement , Exposition professionnelle/effets indésirables , Syndrome parkinsonien secondaire/induit chimiquement , Pesticides/toxicité , Californie , Études cas-témoins , Modèles statistiques , Exposition professionnelle/statistiques et données numériques , Score de propension , Facteurs de risque
3.
Braz. j. med. biol. res ; 47(3): 192-205, 03/2014. graf
Article Dans Anglais | LILACS | ID: lil-704621

Résumé

Numerous studies address the physiology of adipose tissue (AT). The interest surrounding the physiology of AT is primarily the result of the epidemic outburst of obesity in various contemporary societies. Briefly, the two primary metabolic activities of white AT include lipogenesis and lipolysis. Throughout the last two decades, a new model of AT physiology has emerged. Although AT was considered to be primarily an abundant energy source, it is currently considered to be a prolific producer of biologically active substances, and, consequently, is now recognized as an endocrine organ. In addition to leptin, other biologically active substances secreted by AT, generally classified as cytokines, include adiponectin, interleukin-6, tumor necrosis factor-alpha, resistin, vaspin, visfatin, and many others now collectively referred to as adipokines. The secretion of such biologically active substances by AT indicates its importance as a metabolic regulator. Cell turnover of AT has also recently been investigated in terms of its biological role in adipogenesis. Consequently, the objective of this review is to provide a comprehensive critical review of the current literature concerning the metabolic (lipolysis, lipogenesis) and endocrine actions of AT.


Sujets)
Animaux , Humains , Souris , Rats , Adipocytes/métabolisme , Adipogenèse/physiologie , Tissu adipeux blanc/physiologie , Lipolyse/physiologie , Obésité/physiopathologie , Adipokines/métabolisme , Cytokines/métabolisme , Leptine/métabolisme , Nicotinamide phosphoribosyltransferase/métabolisme , Résistine/métabolisme , Transduction du signal/physiologie
SÉLECTION CITATIONS
Détails de la recherche